McArdle JJ, Ferrer-Caja E, Hamagami F, Woodcock RW. Comparative longitudinal structural analyses of the growth and decline of multiple intellectual abilities over the life span. Dev Psychol. 2002;38(1):115–42.
Hakala JO, Pahkala K, Juonala M, Salo P, Kahonen M, Hutri-Kahonen N, Lehtimaki T, Laitinen TP, Jokinen E, Taittonen L, et al. Cardiovascular risk factor trajectories since childhood and cognitive performance in midlife: the cardiovascular risk in young Finns study. Circulation. 2021;143(20):1949–61.
Stoney CM, Kaufmann PG, Czajkowski SM. Cardiovascular disease: psychological, social, and behavioral influences: introduction to the special issue. Am Psychol. 2018;73(8):949–54.
Dove A, Wang J, Huang H, Dunk MM, Sakakibara S, Guitart-Masip M, Papenberg G, Xu W. Diabetes, prediabetes, and brain aging: the role of healthy lifestyle. Diabetes Care. 2024;47(10):1794–802.
Ippoliti F, Canitano N, Businaro R. Stress and obesity as risk factors in cardiovascular diseases: a neuroimmune perspective. J Neuroimmune Pharmacol. 2013;8(1):212–26.
Cuperlovic-Culf M, Badhwar A. Recent advances from metabolomics and lipidomics application in alzheimer’s disease inspiring drug discovery. Expert Opin Drug Discov. 2020;15(3):319–31.
Wouters EJ, van Leeuwen N, Bossema ER, Kruize AA, Bootsma H, Bijlsma JW, Geenen R. Physical activity and physical activity cognitions are potential factors maintaining fatigue in patients with primary sjogren’s syndrome. Ann Rheum Dis. 2012;71(5):668–73.
Arntzen KA, Schirmer H, Wilsgaard T, Mathiesen EB. Impact of cardiovascular risk factors on cognitive function: the Tromso study. Eur J Neurol. 2011;18(5):737–43.
Katzmarzyk PT, Ross R, Blair SN, Despres JP. Should we target increased physical activity or less sedentary behavior in the battle against cardiovascular disease risk development? Atherosclerosis. 2020;311:107–15.
Jia L, Du Y, Chu L, Zhang Z, Li F, Lyu D, Li Y, Li Y, Zhu M, Jiao H, et al. Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in china: a cross-sectional study. Lancet Public Health. 2020;5(12):e661–71.
Petersen RC, Lopez O, Armstrong MJ, Getchius TSD, Ganguli M, Gloss D, Gronseth GS, Marson D, Pringsheim T, Day GS, et al. Practice guideline update summary: mild cognitive impairment [RETIRED]: report of the guideline development, dissemination, and implementation subcommittee of the American academy of neurology. Neurology. 2018;90(3):126–35.
Yuan L, Zhang X, Guo N, Li Z, Lv D, Wang H, Jin J, Wen X, Zhao S, Xu T, et al. Prevalence of cognitive impairment in Chinese older inpatients and its relationship with 1-year adverse health outcomes: a multi-center cohort study. BMC Geriatr. 2021;21(1):595.
Naya DE, Naya H, White CR. On the interplay among ambient temperature, basal metabolic rate, and body mass. Am Nat. 2018;192(4):518–24.
Meng T, Liu C, Wang B, Li C, Liu J, Chen J, Ma Y, Qie R. The protective role of basal metabolic rate in cognitive decline: evidence from epidemiological and genetic studies. Postgrad Med J. 2025;101(1195):417–26.
Wen P, Sun Z, Gou F, Wang J, Fan Q, Zhao D, Yang L. Oxidative stress and mitochondrial impairment: key drivers in neurodegenerative disorders. Ageing Res Rev. 2025;104:102667.
Elzinga SE, Guo K, Turfah A, Henn RE, Webber-Davis IF, Hayes JM, Pacut CM, Teener SJ, Carter AD, Rigan DM, et al. Metabolic stress and age drive inflammation and cognitive decline in mice and humans. Alzheimers Dement. 2025;21(3):e70060.
Cruz-Jentoft AJ, Sayer AA. Sarcopenia Lancet. 2019;393(10191):2636–46.
Soysal P, Ates Bulut E, Yavuz I, Isik AT. Decreased basal metabolic rate can be an objective marker for sarcopenia and frailty in older males. J Am Med Dir Assoc. 2019;20(1):58–63.
Zhang H, Lin S, Gao T, Zhong F, Cai J, Sun Y, Ma A. Association between Sarcopenia and Metabolic Syndrome in Middle-Aged and Older Non-Obese Adults: A Systematic Review and Meta-Analysis. Nutrients 2018, 10(3).
Cho YJ, Lim YH, Yun JM, Yoon HJ, Park M. Sex- and age-specific effects of energy intake and physical activity on sarcopenia. Sci Rep. 2020;10(1):9822.
Du H, Yu M, Xue H, Lu X, Chang Y, Li Z. Association between sarcopenia and cognitive function in older Chinese adults: evidence from the China health and retirement longitudinal study. Front Public Health. 2022;10:1078304.
Beeri MS, Leugrans SE, Delbono O, Bennett DA, Buchman AS. Sarcopenia is associated with incident alzheimer’s dementia, mild cognitive impairment, and cognitive decline. J Am Geriatr Soc. 2021;69(7):1826–35.
Hu Y, Peng W, Ren R, Wang Y, Wang G. Sarcopenia and mild cognitive impairment among elderly adults: the first longitudinal evidence from CHARLS. J Cachexia Sarcopenia Muscle. 2022;13(6):2944–52.
Jacob L, Kostev K, Smith L, Oh H, Lopez-Sanchez GF, Shin JI, Abduljabbar AS, Haro JM, Koyanagi A. Sarcopenia and mild cognitive impairment in older adults from six Low- and Middle-Income countries. J Alzheimers Dis. 2021;82(4):1745–54.
Chen X, Han P, Yu X, Zhang Y, Song P, Liu Y, Jiang Z, Tao Z, Shen S, Wu Y, et al. Relationships between sarcopenia, depressive symptoms, and mild cognitive impairment in Chinese community-dwelling older adults. J Affect Disord. 2021;286:71–7.
Wu B, Lyu YB, Cao ZJ, Wei Y, Shi WY, Gao X, Zhou JH, Kraus VB, Zhao F, Chen X, et al. Associations of sarcopenia, handgrip strength and calf circumference with cognitive impairment among Chinese older adults. Biomed Environ Sci. 2021;34(11):859–70.
Bai A, Xu W, Sun J, Liu J, Deng X, Wu L, Zou X, Zuo J, Zou L, Liu Y, et al. Associations of sarcopenia and its defining components with cognitive function in community-dwelling oldest old. BMC Geriatr. 2021;21(1):292.
Vints WAJ, Kusleikiene S, Sheoran S, Valatkeviciene K, Gleizniene R, Himmelreich U, Paasuke M, Cesnaitiene VJ, Levin O, Verbunt J, et al. Body fat and components of sarcopenia relate to inflammation, brain volume, and neurometabolism in older adults. Neurobiol Aging. 2023;127:1–11.
Zhao Y, Hu Y, Smith JP, Strauss J, Yang G. Cohort profile: the China health and retirement longitudinal study (CHARLS). Int J Epidemiol. 2014;43(1):61–8.
Ding R, He P. Associations between childhood adversities and late-life cognitive function: potential mechanisms. Soc Sci Med. 2021;291:114478.
Lu N, Wu B, Pei Y. Exploring the reciprocal relationship between cognitive function and edentulism among middle-aged and older adults in China. Age Ageing. 2021;50(3):809–14.
Bai A, Shi H, Huang X, Xu W, Deng Y. Association of C-Reactive protein and motoric cognitive risk syndrome in Community-Dwelling older adults: the China health and retirement longitudinal study. J Nutr Health Aging. 2021;25(9):1090–5.
Jak AJ, Bondi MW, Delano-Wood L, Wierenga C, Corey-Bloom J, Salmon DP, Delis DC. Quantification of five neuropsychological approaches to defining mild cognitive impairment. Am J Geriatr Psychiatry. 2009;17(5):368–75.
Mifflin MD, St Jeor ST, Hill LA, Scott BJ, Daugherty SA, Koh YO. A new predictive equation for resting energy expenditure in healthy individuals. Am J Clin Nutr. 1990;51(2):241–7.
Chen LK, Woo J, Assantachai P, Auyeung TW, Chou MY, Iijima K, Jang HC, Kang L, Kim M, Kim S, et al. Asian working group for sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc. 2020;21(3):300–7. e302.
Gao K, Cao LF, Ma WZ, Gao YJ, Luo MS, Zhu J, Li T, Zhou D. Association between sarcopenia and cardiovascular disease among middle-aged and older adults: findings from the China health and retirement longitudinal study. EClinicalMedicine. 2022;44:101264.
Wen X, Wang M, Jiang CM, Zhang YM. Anthropometric equation for Estimation of appendicular skeletal muscle mass in Chinese adults. Asia Pac J Clin Nutr. 2011;20(4):551–6.
Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol. 1986;51(6):1173–82.
Beard E, Lengacher S, Dias S, Magistretti PJ, Finsterwald C. Astrocytes as key regulators of brain energy metabolism: new therapeutic perspectives. Front Physiol. 2021;12:825816.
Ryu WI, Bormann MK, Shen M, Kim D, Forester B, Park Y, So J, Seo H, Sonntag KC, Cohen BM. Brain cells derived from alzheimer’s disease patients have multiple specific innate abnormalities in energy metabolism. Mol Psychiatry. 2021;26(10):5702–14.
Nelson ME, Veal BM, Andel R, Martinkova J, Veverova K, Horakova H, Nedelska Z, Laczo J, Vyhnalek M, Hort J. Moderating effect of cognitive reserve on brain integrity and cognitive performance. Front Aging Neurosci. 2022;14:1018071.
Ito H, Kubo H, Takahashi K, Nishijima KI, Ukon N, Nemoto A, Sugawara S, Yamakuni R, Ibaraki M, Ishii S. Integrated PET/MRI scanner with oxygen-15 labeled gases for quantification of cerebral blood flow, cerebral blood volume, cerebral oxygen extraction fraction and cerebral metabolic rate of oxygen. Ann Nucl Med. 2021;35(4):421–8.
Fleming V, Piro-Gambetti B, Patrick A, Zammit M, Alexander A, Christian BT, Handen B, Cohen A, Klunk W, Laymon C, et al. Physical activity and cognitive and imaging biomarkers of alzheimer’s disease in down syndrome. Neurobiol Aging. 2021;107:118–27.
Yan X, Hu Y, Wang B, Wang S, Zhang X. Metabolic dysregulation contributes to the progression of alzheimer’s disease. Front Neurosci. 2020;14:530219.
Yin J, Reiman EM, Beach TG, Serrano GE, Sabbagh MN, Nielsen M, Caselli RJ, Shi J. Effect of ApoE isoforms on mitochondria in alzheimer disease. Neurology. 2020;94(23):e2404–11.
Guzzardi MA, Iozzo P. Brain functional imaging in obese and diabetic patients. Acta Diabetol. 2019;56(2):135–44.
Molloy JW, Barry D. The interplay between glucose and ketone bodies in neural stem cell metabolism. J Neurosci Res. 2024;102(5):e25342.
Guan L, Li T, Wang X, Yu K, Xiao R, Xi Y. Predictive Roles of Basal Metabolic Rate and Body Water Distribution in Sarcopenia and Sarcopenic Obesity: The link to Carbohydrates. Nutrients 2022, 14(19).
Cho YJ, Cho MH, Han B, Park M, Bak S, Park M. The association between the ratio of energy intake to basal metabolic rate and physical activity to sarcopenia: using the Korea National health and nutrition examination surveys (2008–2011). Korean J Fam Med. 2020;41(3):167–74.
Alfaro-Acha A, Al Snih S, Raji MA, Kuo YF, Markides KS, Ottenbacher KJ. Handgrip strength and cognitive decline in older Mexican Americans. J Gerontol Biol Sci Med Sci. 2006;61(8):859–65.
Kim GR, Sun J, Han M, Nam CM, Park S. Evaluation of the directional relationship between handgrip strength and cognitive function: the Korean longitudinal study of ageing. Age Ageing. 2019;48(3):426–32.
Buchman AS, Bennett DA. Loss of motor function in preclinical alzheimer’s disease. Expert Rev Neurother. 2011;11(5):665–76.
Yang J, Deng Y, Yan H, Li B, Wang Z, Liao J, Cai X, Zhou L, Tan W, Rong S. Association between grip strength and cognitive function in US older adults of NHANES 2011–2014. J Alzheimers Dis. 2022;89(2):427–36.
Aoi W, Sakuma K. Oxidative stress and skeletal muscle dysfunction with aging. Curr Aging Sci. 2011;4(2):101–9.
Mangialasche F, Polidori MC, Monastero R, Ercolani S, Camarda C, Cecchetti R, Mecocci P. Biomarkers of oxidative and nitrosative damage in alzheimer’s disease and mild cognitive impairment. Ageing Res Rev. 2009;8(4):285–305.
Cesari M, Penninx BW, Pahor M, Lauretani F, Corsi AM, Rhys Williams G, Guralnik JM, Ferrucci L. Inflammatory markers and physical performance in older persons: the InCHIANTI study. J Gerontol Biol Sci Med Sci. 2004;59(3):242–8.
Lejri I, Agapouda A, Grimm A, Eckert A. Mitochondria- and Oxidative Stress-Targeting Substances in Cognitive Decline-Related Disorders: From Molecular Mechanisms to Clinical Evidence. Oxid Med Cell Longev 2019, 2019:9695412.
Cheng Y, Lin S, Cao Z, Yu R, Fan Y, Chen J. The role of chronic low-grade inflammation in the development of sarcopenia: advances in molecular mechanisms. Int Immunopharmacol. 2025;147:114056.
Cunningham C, Hennessy E. Co-morbidity and systemic inflammation as drivers of cognitive decline: new experimental models adopting a broader paradigm in dementia research. Alzheimers Res Ther. 2015;7(1):33.
Cho SH, Chen JA, Sayed F, Ward ME, Gao F, Nguyen TA, Krabbe G, Sohn PD, Lo I, Minami S, et al. SIRT1 deficiency in microglia contributes to cognitive decline in aging and neurodegeneration via epigenetic regulation of IL-1beta. J Neurosci. 2015;35(2):807–18.
Shigehara K, Kato Y, Izumi K, Mizokami A. Relationship between testosterone and sarcopenia in Older-Adult men: A narrative review. J Clin Med. 2022;11(20).
Bahat G, Ozkok S, Petrovic M. Management of type 2 diabetes in frail older adults. Drugs Aging. 2023;40(9):751–61.